The Wonder Drug for Weight Loss Breaks into a New Country!
The Danish pharmaceutical giant announced that the weekly injectable medication will initially be available in the United Kingdom under a "controlled and limited launch," and only certain patients will be able to receive the drug through the country’s National Health Service (NHS). To be eligible for treatment, patients must be part of the NHS weight management service, suffer from at least one weight-related condition, and have a body mass index (BMI) of 35, according to guidelines set by the National Institute for Health and Care Excellence (NICE). The drug will also be available privately through a "registered healthcare professional," Novo Nordisk stated in its announcement, without providing further details. Novo Nordisk has also not disclosed the final price agreed upon with NHS England, but stated that NICE, the UK’s drug cost-effectiveness watchdog, has deemed the pricing "cost-effective." The Danish company added that the private market price ...